Friday, December 5, 2025 ~ BREAKOUT SESSION
BREAKOUT SESSION I | Therapies of Tomorrow
​
Location: Hatch Auditorium
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Dimple Chakravarty, PhD, Sujit Nair, PhD, Babu Padanilam, PhD
Targeting Cellular Stress; The Chaperon Network as a Therapeutic Gateway in Kidney Cancer
Mehdi Mollapur, PhD
10:00am
10:20am
Neoantigen Cancer Vaccines
Nina Bhardwaj, MD, PhD
10:40am
Renal Injury; Unlocking the Biology of Recovery
Babu Padanilam, PhD
11:00am
Status of Genomic Testing in CRPC
William Oh, MD
11:20am
Role of Theranostics and PARP Inhibitors
Cora Sternberg, MD, FACP
11:40am
Novel Immunotherapy Approaches for Prostate Cancer
Susan Slovin, MD, PhD
12:00pm
RETURN TO MAIN SESSION
BREAKOUT SESSION II | What’s Next: Evolving Therapies and Trials in Advanced Prostate Cancer
​
Moderator: Ugo Falagario, MD
Panel: Christina Jamieson, PhD, Bobby Liaw, MD
1:40pm
Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
Ugo Falagario, MD
2:00pm
Advanced Staged PCa (Research)
Christina Jamieson, PhD
2:20pm
Treatment De-Escalation in Metastatic Hormone-Sensitive PCa
Bobby Liaw, MD
2:40pm
Risk-Adapted Neoadjuvant Trials in Prostate Cancer
Dimple Chakravarty, PhD
3:00pm
Can the Molecular Landscape Define the Clinical Management of Patients with Advanced Prostate Cancer?
Natasha Kyprianou, MBBS, PhD
3:20pm
Prostate Cancer Vaccine Trials
Sujit Nair, PhD
SESSION III | The New Horizon: Evolving Strategies in Advanced and Metastatic Disease
​​
​Covering the latest in systemic therapies, PSMA imaging, and molecular approaches for advanced cases
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Sujit Nair, PhD, Angelo De Marzo, MD, PhD, Goutam Chakraborty, PhD
3:40pm
Quantitative Ultrasound Innovations and Applications to Kidney and Prostate Cancers
Jonathan Mamou, PhD
3:55pm
Inflammation in Prostate Carcinogenesis
Angelo M. De Marzo, MD, PhD
4:10pm
Organoid-Guided Therapeutic Profiling in GU Cancers
Benjamin D. Hopkins, PhD
4:25pm
PET Imaging and Radiotheranostics in Prostate Cancer
Salomon Tendler, MD
4:40pm
Neoadjuvant Apalutamide and Downstaging Prostate Cancer
Isaac Kim, MD, PhD, MBA
4:55pm
End of Session